GANX
Price
$1.76
Change
+$0.02 (+1.15%)
Updated
Sep 5 closing price
Capitalization
63.27M
62 days until earnings call
NNVC
Price
$1.49
Change
+$0.11 (+7.97%)
Updated
Sep 5 closing price
Capitalization
23.95M
88 days until earnings call
Interact to see
Advertisement

GANX vs NNVC

Header iconGANX vs NNVC Comparison
Open Charts GANX vs NNVCBanner chart's image
Gain Therapeutics
Price$1.76
Change+$0.02 (+1.15%)
Volume$502.53K
Capitalization63.27M
NanoViricides
Price$1.49
Change+$0.11 (+7.97%)
Volume$255.71K
Capitalization23.95M
GANX vs NNVC Comparison Chart in %
Loading...
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GANX vs. NNVC commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GANX is a Hold and NNVC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (GANX: $1.76 vs. NNVC: $1.49)
Brand notoriety: GANX and NNVC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GANX: 133% vs. NNVC: 124%
Market capitalization -- GANX: $63.27M vs. NNVC: $23.95M
GANX [@Biotechnology] is valued at $63.27M. NNVC’s [@Biotechnology] market capitalization is $23.95M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GANX’s FA Score shows that 0 FA rating(s) are green whileNNVC’s FA Score has 1 green FA rating(s).

  • GANX’s FA Score: 0 green, 5 red.
  • NNVC’s FA Score: 1 green, 4 red.
According to our system of comparison, NNVC is a better buy in the long-term than GANX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GANX’s TA Score shows that 4 TA indicator(s) are bullish while NNVC’s TA Score has 6 bullish TA indicator(s).

  • GANX’s TA Score: 4 bullish, 6 bearish.
  • NNVC’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, NNVC is a better buy in the short-term than GANX.

Price Growth

GANX (@Biotechnology) experienced а -11.56% price change this week, while NNVC (@Biotechnology) price change was +7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

GANX is expected to report earnings on Nov 07, 2025.

NNVC is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GANX($63.3M) has a higher market cap than NNVC($23.9M). NNVC YTD gains are higher at: 4.196 vs. GANX (-18.519). NNVC has higher annual earnings (EBITDA): -8.95M vs. GANX (-17.16M). GANX has more cash in the bank: 6.69M vs. NNVC (2.54M). GANX has less debt than NNVC: GANX (681K) vs NNVC (1.5M). GANX (0) and NNVC (0) have equivalent revenues.
GANXNNVCGANX / NNVC
Capitalization63.3M23.9M265%
EBITDA-17.16M-8.95M192%
Gain YTD-18.5194.196-441%
P/E RatioN/AN/A-
Revenue00-
Total Cash6.69M2.54M263%
Total Debt681K1.5M45%
FUNDAMENTALS RATINGS
NNVC: Fundamental Ratings
NNVC
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GANXNNVC
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 27 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
GANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NNVC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMREF0.100.01
+12.78%
Sun Summit Minerals Corp
CNLTL31.000.01
+0.03%
Connecticut Light & Power Co. (The)
FBSFF18.00N/A
N/A
Fabasoft AG
WJRYF24.03N/A
N/A
West Japan Railway Co.
APMSF30.50N/A
N/A
Aperam S.A.

GANX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GANX has been loosely correlated with COYA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GANX jumps, then COYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GANX
1D Price
Change %
GANX100%
+1.15%
COYA - GANX
37%
Loosely correlated
-1.72%
EYPT - GANX
33%
Loosely correlated
+17.93%
ELVN - GANX
32%
Poorly correlated
+0.70%
WVE - GANX
32%
Poorly correlated
+1.34%
OCUL - GANX
31%
Poorly correlated
+7.09%
More

NNVC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NNVC has been loosely correlated with TYRA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NNVC jumps, then TYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NNVC
1D Price
Change %
NNVC100%
+8.36%
TYRA - NNVC
34%
Loosely correlated
+4.20%
MRUS - NNVC
32%
Poorly correlated
+1.87%
GOSS - NNVC
32%
Poorly correlated
+17.13%
GANX - NNVC
29%
Poorly correlated
+1.15%
LEGN - NNVC
29%
Poorly correlated
+3.12%
More